Stem cells are the ideal for cell based therapies. Harnessing cells for use as directed therapies has hot an impasse for solid tissues that HOF Therapeutics has solved with its Cell Assembly Programming (CAP). Stem cells are the best source for CAP organs, and can also be mixed with cells from other sources.  There must be acknowledgement from funding sources for stem cell research that implementation of cures are still missing a key enabling technology to be clinically useful.  The clinical deficiency is not in the wrong cells being used rather the cells are not prepared correctly to be integrated into the body. HOF's CAP technology needs support to finally enable the promise of stem cell therapy. We are seeking partners for our endeavors. 

Embryonic Stem Cells